Optimizing the Treatment of CRPS With Ketamine

Area of Science:

• Pain Medicine
• Neurology
• Pharmacology

Background:

• Complex Regional Pain Syndrome (CRPS) is a debilitating chronic pain condition.
• Objective measurement of treatment efficacy for CRPS has been a significant challenge.
• Ketamine infusions show promise for CRPS management, but optimal dosing and duration remain unclear.

Purpose of the Study:

• To develop an objective method for measuring the clinical benefits of ketamine infusions in CRPS patients.
• To establish optimal ketamine dosing and treatment duration for CRPS based on objective measures.
• To correlate quantitative sensory testing (QST) findings with clinical outcomes in CRPS.

Main Methods:

• Outpatient, 4-day escalating dose ketamine infusions were administered to CRPS patients with hyperalgesia.
• Pain thresholds were objectively measured using quantitative sensory testing (QST).
• Clinical outcomes were assessed independently of pain threshold measurements.

Main Results:

• A significant correlation was observed between pain thresholds and patient-reported pain intensity.
• Improvements in pain thresholds directly correlated with positive clinical outcomes.
• Pain thresholds for lower extremities plateaued between days 3 and 4, suggesting treatment sufficiency.
• No plateau in pain thresholds was observed for upper extremities, indicating a need for potentially longer treatment.

Conclusions:

• Four days of ketamine infusion may be sufficient for treating CRPS in the lower extremities.
• CRPS affecting the upper extremities might necessitate ketamine infusions longer than 4 days.
• This study pioneers the use of QST to guide the treatment of chronic pain disorders like CRPS.